Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
William Blair launched coverage of Stryker Corporation (NYSE: SYK) with an Outperform rating, pointing to the medical technology company's diversified product mix, recent acquisitions and margin profile. The firm highlighted Stryker's expansion into new clinical areas and data-driven offerings, while noting international expansion and ambulatory su…
Barclays has initiated coverage of Gilead Sciences Inc. with an Equalweight rating and a $155 price target, citing a return to the company’s infectious-disease focus but noting that recent share gains and valuation compress the upside. Gilead’s Q4 2025 results topped expectations and several peers raised targets, while others remained cautious.
Barclays has begun coverage of Pfizer Inc. with an underweight rating and a $25 price target, pointing to imminent patent expirations and a company emphasis on reducing leverage. The bank expects limited share movement until clinical and pipeline updates arrive, even as other firms maintain higher price targets and Pfizer posts stronger-than-expect…
Barclays has initiated coverage of Biogen Inc. with an Equalweight rating and a $185.00 price target. Analyst Carter Gould cited tangible commercial and pipeline improvements but tempered upside until more pipeline data arrives. The stock currently trades above the new target, and recent fourth-quarter results and revisions from other firms have dr…
Barclays initiated coverage of Merck & Co. (MRK) with an overweight rating and set a $140 price target, pointing to a slate of product launches and clinical readouts expected to materialize in 2026. The firm emphasized the potential impact of enlicitide - the first oral PCSK9 inhibitor - and pivotal data from tulisokibart’s ATLAS-UC study, the …
Barclays has initiated coverage of Bristol-Myers Squibb Co. (NYSE: BMY) with an overweight rating and a $75 price target, implying roughly 24% upside from the current $60.30 share price. The broker highlights early signs of progress in the company’s pipeline as it prepares for looming patent expirations on Eliquis and Opdivo, and anticipates upward…
Barclays has initiated coverage of Eli Lilly with an overweight rating and a $1,350 price target, pointing to the company’s leading role in the expanding obesity treatment market driven by GLP-1 therapies. The bank framed medical treatment of obesity as a structural shift and defended Lilly’s premium valuation against broader pharmaceutical peers. …
Barclays has begun coverage of AbbVie Inc. with an overweight rating and a $275.00 price target, highlighting the company's potential for operating leverage that the market may not yet fully price. The target implies roughly 23% upside from a reference quote of $224.35. The bank expects 2026 will offer a series of proof-of-concept data readouts acr…
A mixed holiday schedule left markets navigating a volatile week in which crude oil jumped to its highest level since August amid rising Gulf tensions. At the same time, signs of stronger US manufacturing and labour data have supported demand expectations, while heavy AI investment plans among major technology firms and circular capital flows are p…
Global equity funds recorded their biggest weekly net inflow in five weeks during the seven days to February 18, receiving $36.33 billion as risk appetite broadened beyond artificial intelligence names and hopes for Federal Reserve rate cuts improved. European funds led regional flows while U.S. and Asian funds also drew substantial purchases. Bond…
Shares of BE Semiconductor Industries regained ground on Friday, rising more than 4% after Morgan Stanley reiterated its bullish view following a guidance-related selloff. The Dutch equipment maker reported results and guidance broadly in line with expectations, but a lack of upside prompted an earlier 7.5% one-day drop. Morgan Stanley kept its inv…
Huntsman (HUN) trades at a sub-1x price-to-book and roughly 0.4x price-to-sales while producing meaningful free cash flow. A $0.0875/share dividend and secular demand tailwinds in polyurethanes, TPU and amines create a favorable entry for patient investors. This trade idea lays out an entry, stop and target across time horizons and highlights the o…
Piper Sandler is advising investors to exercise restraint following a constructive but fragile market rebound. The firm highlights that key indexes remain below their 50-day moving averages, momentum measures are cooling, and recent gains have shown limited follow-through. Energy stands out as a relative leader, supported by crude oil's setup near …
King Charles’ younger brother, Andrew Mountbatten-Windsor, was arrested on suspicion of misconduct in public office over allegations he sent confidential government documents to Jeffrey Epstein. He was questioned for several hours by Thames Valley Police and released under investigation. The probe follows previously released U.S. files and separate…
BofA Securities economists expect the Federal Reserve to reduce interest rates at its June and July 2026 meetings, even though they argue that underlying economic signals - including a falling unemployment rate and a recent uptick in the Fed’s preferred inflation gauge - do not support such moves. The projection comes amid debate over the policy st…
Duolingo Inc. Chief Business Officer Robert Meese disposed of 1,000 Class A shares on February 17, 2026, realizing $110,060. The transaction was executed to satisfy tax withholding tied to vesting restricted stock units. Meese continues to hold a substantial equity position directly and indirectly. The sale arrives amid a range of analyst opinions …
Canaccord Genuity has launched coverage of Terra Innovatum Global (NASDAQ:NKLR) with a Buy rating and a price target of $10. The broker’s valuation rests on a discounted cash flow model that runs to 2050 and assumes a roughly 15% weighted average cost of capital and a roughly 5% terminal growth rate. Canaccord cites growth in nuclear capacity and t…
Mizuho upgraded Southern Co. (SO) to Outperform from Neutral and increased its price target to $104 from $89, driven by a view that the utility's regulated footprint and multi-year growth profile merit a larger valuation premium. The firm raised its assumed price-to-earnings premium to 15% from 5%, even as analysis flags the shares as overvalued re…
The market is bracing for Nvidia’s fiscal fourth-quarter report and a slate of software earnings that could shape sentiment for AI-exposed stocks. Nvidia’s results and CEO commentary are in focus after heavy gains in recent years, while software firms face pressure amid concerns that artificial intelligence will disrupt their business models. Broad…
The Trump administration announced a rollback of the Mercury and Air Toxics Standard for coal-fired power plants, arguing that relaxed limits will ease costs for operators of aging generators and support rising electricity demand driven by the expansion of AI data centers. Environmental and public health groups say the move will increase exposure t…
Duolingo General Counsel Stephen C. Chen sold a combined 2,797 shares of Class A common stock on February 17 and 18, 2026, generating total proceeds of $313,926. The February 18 transactions were carried out under a Rule 10b5-1 trading plan adopted in May 2025. After the sales Chen holds 30,545 shares. The stock has been trading near its 52-week lo…
Duolingo Chief Engineering Officer Natalie Glance sold $594,016 of Class A Common Stock across multiple transactions on February 17 and 18 under a Rule 10b5-1 trading plan. The sales occurred as Duolingo shares traded close to a 52-week low and amid a split among analysts over the company’s growth prospects and AI-driven product development.
Duolingo Chief Financial Officer Matthew Skaruppa sold $658,303 of Class A common stock across transactions on February 17 and 18, according to a Form 4 filing. The disposals were carried out under a Rule 10b5-1 trading plan adopted May 27, 2025. The trades occurred while Duolingo shares traded close to their 52-week low of $107.16 and after recent…
Deutsche Bank has moved Telecom Italia and its savings shares from 'buy' to 'hold' after the stock climbed roughly 40% since early October. The bank raised its target prices slightly but said the recent rally has already absorbed much of the upside tied to spectrum expiries and an anticipated free cash flow recovery.
Wells Fargo downgraded Molina Healthcare to Equal Weight from Overweight and cut its price target to $141 from $208, citing disappointing fourth-quarter 2025 results and increasing uncertainty around revenue and expense accruals. The firm revised down Molina's 2026 earnings outlook and raised questions about the company's assumptions for Medicaid c…
